President Donald Trump stepped up criticism of opioid drug manufacturers. He recently intimated he was considering suing drugmakers for their role in fueling the opioid crisis:
A number of cities, counties and states have already sued opioid manufacturers. Last month, Attorney General Jeff Sessions said he was creating a task force to examine companies’ role in the epidemic and was ordering it “to examine existing state and local government lawsuits against opioid manufacturers to determine if we can be of assistance.”
“Our Department of Justice is looking very seriously at bringing major litigation against some of these drug companies,” Trump said Monday. “We’ll bring it at a federal level. Some states are already bringing it, but we’re thinking about bringing it at a very high federal level and we’ll do a job.”
The President made the critical remarks at a speech in New Hampshire. Trump declared that companies responsible for the epidemic must be held accountable. I believe Mallinckrodt (MNK), Endo (ENDO) and Insys (INSY) are particularly vulnerable to potential fines, penalties or litigation.
What about Purdue, the greatest offender.
Are you not interested because they are not public?
Joe Smoe,
Agreed. Purdue is one of the biggest offenders. Since it is not publicly-traded the Shock Exchange rarely writes about it. He usually only covers publicly-traded companies.
Jo Smoe,
The Shock Exchange is interested in Purdue. He rarely writes about it since it’s not publicly-traded. Purdue is likely the king of opioids and trumps Endo, Mallinckrodt, Allergan, J&J, Teva, Depomed, and Insys.